We are live on ! Find out more
OWD

Osborn Williams & Donohoe Portfolio holdings

AUM $762M
1-Year Est. Return 2.74%
This Fund
S&P 500
This Quarter Est. Return
+10.48%
1 Year Est. Return
-2.74%
3 Year Est. Return
+23.69%
5 Year Est. Return
+43.75%
10 Year Est. Return
–
AUM
$1B
AUM Growth
+$7.18M
Cap. Flow
-$69.8M
Cap. Flow %
-6.98%
Top 10 Hldgs %
22.66%
Holding
320
New
18
Increased
64
Reduced
177
Closed
18

Top Buys

Rank Stock Value
1
ACN icon
Accenture
ACN
+$7.51M
2
TGT icon
Target
TGT
+$3.7M
3
BMY icon
Bristol-Myers Squibb
BMY
+$2.17M
4
BALL icon
Ball Corp
BALL
+$835K
5
RWT
Redwood Trust
RWT
+$832K

Top Sells

Rank Stock Value
1
CINF icon
Cincinnati Financial
CINF
+$8.78M
2
CELG
Celgene Corp
CELG
+$3.9M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$2.24M
4
IYC icon
iShares US Consumer Discretionary ETF
IYC
+$2.08M
5
MSFT icon
Microsoft
MSFT
+$1.86M

Sector Composition

Rank Sector Weight
1 Financials 16.37%
2 Technology 16.27%
3 Healthcare 16.13%
4 Consumer Staples 10.21%
5 Industrials 8.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PG icon
1
Procter & Gamble
PG
$347B
$39M 3.9%
311,890
-5,305
-2% -$649K
AAPL icon
2
Apple
AAPL
$4.8T
$36M 3.6%
490,884
-27,120
-5% -$1.74M
MSFT icon
3
Microsoft
MSFT
$2.99T
$28.2M 2.82%
178,899
-12,635
-7% -$1.86M
CINF icon
4
Cincinnati Financial
CINF
$27.9B
$21.1M 2.11%
200,361
-80,323
-29% -$8.78M
INTC icon
5
Intel
INTC
$488B
$17.9M 1.79%
298,719
-25,802
-8% -$1.44M
SYK icon
6
Stryker
SYK
$122B
$17.3M 1.73%
82,391
-5,216
-6% -$1.08M
V icon
7
Visa
V
$686B
$17.2M 1.72%
91,703
-6,102
-6% -$1.1M
RETA
8
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$16.9M 1.69%
82,773
+1,865
+2% +$340K
JNJ icon
9
Johnson & Johnson
JNJ
$599B
$16.7M 1.67%
114,765
-11,397
-9% -$1.55M
NKE icon
10
Nike
NKE
$64.5B
$16.3M 1.63%
160,765
-6,549
-4% -$617K
DIS icon
11
Walt Disney
DIS
$167B
$15.9M 1.59%
110,206
-3,688
-3% -$515K
AMAT icon
12
Applied Materials
AMAT
$417B
$15.9M 1.59%
259,763
-30,446
-10% -$1.71M
PEP icon
13
PepsiCo
PEP
$185B
$15.3M 1.53%
111,759
-8,268
-7% -$1.13M
BLK icon
14
Blackrock
BLK
$163B
$14.9M 1.49%
29,608
-3,372
-10% -$1.6M
CSCO icon
15
Cisco
CSCO
$436B
$13.9M 1.39%
290,101
-6,968
-2% -$324K
JPM icon
16
JPMorgan Chase
JPM
$901B
$13.7M 1.37%
98,256
-3,255
-3% -$417K
RPM icon
17
RPM International
RPM
$13B
$13.5M 1.35%
176,216
-9,426
-5% -$684K
ABT icon
18
Abbott
ABT
$177B
$13.5M 1.35%
155,053
-5,683
-4% -$476K
RTX icon
19
RTX Corp
RTX
$262B
$12.6M 1.26%
133,360
-15,733
-11% -$1.43M
ABBV icon
20
AbbVie
ABBV
$448B
$11.8M 1.18%
133,337
-8,814
-6% -$732K
CVS icon
21
CVS Health
CVS
$137B
$11.6M 1.16%
156,296
-11,610
-7% -$815K
ECL icon
22
Ecolab
ECL
$75.6B
$11.6M 1.16%
60,028
-2,749
-4% -$522K
DHR icon
23
Danaher
DHR
$142B
$11.6M 1.16%
84,905
-4,210
-5% -$532K
CVX icon
24
Chevron
CVX
$378B
$11.4M 1.14%
94,194
-8,777
-9% -$1.03M
SBUX icon
25
Starbucks
SBUX
$119B
$11.1M 1.11%
126,464
-5,677
-4% -$484K
1
2 3 4 5

Similar funds

AVC
Arlington Value Capital Salt Lake City, Utah $688M AUM 23.52% 1-Year Est. Return
EA
Echinus Advisors New York $881M AUM 6.76% 1-Year Est. Return
ECP
Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return
BAC
Boys Arnold & Co Asheville, North Carolina $566M AUM 6.76% 1-Year Est. Return
CEP
Chicago Equity Partners Chicago, Illinois $993M AUM 6.42% 1-Year Est. Return
PP
PagnatoKarp Partners Reston, Virginia $402M AUM 9.79% 1-Year Est. Return
WWM
Willingdon Wealth Management Huntersville, North Carolina $397M AUM 1.25% 1-Year Est. Return
JA
JOYN Advisors Atlanta, Georgia $300M AUM 14.91% 1-Year Est. Return

Osborn Williams & Donohoe's Q4 2019 Portfolio in Review

As of Q4 2019, Osborn Williams & Donohoe held 320 positions worth $1B, up 0.72% from $993M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Osborn Williams & Donohoe withdrew a net $69.8M in Q4 2019, closing 18 positions and reducing 177 holdings. Its most notable exit was Celgene Corp, an estimated $3.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 18% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Osborn Williams & Donohoe opened a new position in Accenture worth $8.11M.

  • Osborn Williams & Donohoe's largest Q4 2019 buy was Accenture: 38,523 shares worth $8.11M.
  • Osborn Williams & Donohoe added most to Bristol-Myers Squibb in Q4 2019, an estimated $2.17M increase.
  • Osborn Williams & Donohoe's biggest Q4 2019 reduction was Cincinnati Financial, cutting an estimated $8.78M.
  • Osborn Williams & Donohoe fully exited Celgene Corp in Q4 2019, selling an estimated $3.9M.
  • Osborn Williams & Donohoe's ten largest holdings make up 23% of its $1B portfolio in Q4 2019.
  • Osborn Williams & Donohoe opened 18 new positions and closed 18 in Q4 2019.
  • Osborn Williams & Donohoe's portfolio value rose 0.72% quarter-over-quarter to $1B.

Based on Osborn Williams & Donohoe's 13F filing for Q4 2019, filed 2 Mar 2020.